Print this page

Paraquat chemical review

In progress

Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.

Vertical Tabs

Work plan

Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.

Chemicals	Paraquat

1. Nomination

Phase status:

Completed

Paraquat active constituents, chemical products and labels were nominated for review in response to an invitation to the public by the APVMA (then the NRA) on 1 November 1994. Eighty of the nominated chemicals, including paraquat, were included in the priority candidate review list published in the Gazette on 2 May 1995.

2. Prioritisation

Phase status:

Completed

3. Scoping and work plan

Phase status:

Completed

The scope of the review includes reconsideration of paraquat active constituents, chemical products and labels through assessments related to residues, environment and human health, including work health and safety.

The work plan was first published on 1 July 2015.

4. Notice of reconsideration

Phase status:

Completed

The s 32 notice of reconsideration for active constituents, chemical products and labels for paraquat was published in the Gazette on 2 December 1997. The deadline for submissions was 31 May 1998 and was extended until 30 September 1998 as published in the Gazette on 7 April 1998

The s 32 notice of reconsideration was given to holders and chemical coordinators of the states and territories upon commencement of the review on 27 October 1997.

Additional s 32 notices were sent to holders on 4 March 1998 to request technical data. The deadline for submissions was 30 September 1998.

Additional s 32 notices were sent to holders on 1 July 2015 to include all approved actives and registered products in the review.

Additional s 32 notices were sent to holders on 10 May 2016 to include all approved actives and registered products in the review.

Additional s 32 notices were sent to holders on 16 August 2017 to include all approved actives and registered products in the review.

5. Assessment

Phase status:

In Progress

When the component risk assessments have been completed, the proposed regulatory decisions will be drafted.

6. Proposed regulatory decision

Phase status:

Forecasted

Publication of the proposed regulatory decision is expected in mid-2022.

7. Consultation

Phase status:

Forecasted

The legislated timeframe for consultation following publication of the proposed regulatory decision is 3 months.

8. Final regulatory decision

Phase status:

Forecasted

Following the close of the public consultation period on the proposed regulatory decision, and consideration of submissions received, the final regulatory decision will be published.

9. Implementation

Phase status:

Forecasted

The implementation period will begin on the date the final regulatory decision is made.

Publication archive

Type	Title	Publication date
Report	Paraquat toxicology report – summary	26 October 2016
Report	Paraquat toxicology report – supplement I toxicology	26 October 2016
Report	Paraquat toxicology report – supplement II neurotoxicology	26 October 2016